Germany: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

LD Hamburg, October 21, 2025, Order In The Proceedings For Provisional Measures, UPC_CFI_553/2025

To establish jurisdiction, at least the plausible allegation of infringing acts in the country in question is necessary.

BP

Bardehle Pagenberg

Herbert Smith Freehills Kramer Comments For LSIPR On Small Molecule Litigation In The UPC

Life sciences-related cases started at a low level during the first years of the UPC's existence (about 25% of cases) and focused initially on the medtech sector.

KL

Herbert Smith Freehills Kramer LLP

European Biosimilar Updates – Formycon's Ustekinumab And Alvotech's Cetrolizumab Pegol

On June 26, 2025, Formycon AG ("Formycon") announced a distribution agreement with Teva Group subsidiary Ratiopharm GmbH ("Ratiopharm") for the semi-exclusive commercialization...

Germany Healthcare

GP

Goodwin Procter LLP

Nordic-Baltic Regional Division, July 21, 2025, Decision In First Instance, UPC_CFI_380/2023

The importance of the patent claims means, inter alia, that a narrowing interpretation of the claims which deviates from the broader general understanding of the terms used therein by the person...

BP

Bardehle Pagenberg

Konsultation der EU-Kommission zu Hochrisiko-KI-Systemen: Kernpunkte für den Life Sciences- und Health Care-Sektor

Germany Technology

GT

Greenberg Traurig, LLP

EU Commission Consultation On High-Risk AI Systems: Key Points For Life Sciences And Health Care

European Union Healthcare

GT

Greenberg Traurig, LLP

Second Medical Use Claims In The UPC System: Prerequisites And Mechanism Of Examination For Infringement

Germany Healthcare

BP

Bardehle Pagenberg

New German Government: Key Plans For The Life Sciences And Healthcare Sector

Germany Healthcare

AO

A&O Shearman

New CJEU Ruling On The Borderline Between Medicinal Products And Medical Devices: Key Takeaways

Germany Healthcare

AO

A&O Shearman

The CJEU Issues New Ruling On Advertising Of Medicinal Products

Germany Media & IT

P

Plesner

RD Nordic-Baltic, January 21, 2025, Procedural Order On Costs For Access To Pleadings And Evidence, UPC_CFI_380/2023

BP

Bardehle Pagenberg

Key Regulatory Changes Impacting The Healthcare Industry In The EU And Germany In 2025

European Union Healthcare

AO

A&O Shearman

CD Paris, 23 September 2024, Public Access To File, UPC_CFI_189/2024

European Union IP

BP

Bardehle Pagenberg

EU Parliament Adopts SPC Reform Proposals: Clarifying The Protection Scope For Biologics

European Union IP

JD

Jones Day

Investment Management Client Alert September 2025

Germany Commercial

KG

K&L Gates LLP

Alvarez & Marsal Webinar: European Restructuring And Corporate Distress In 2025 (Video)

Germany Insolvency

AM

Alvarez & Marsal

Digitalisierung des Kapitalmarkts: Der europäische Rechtsrahmen im Umbruch

Germany Finance

MB

Mayer Brown

SOC-reports: Building Trust Through Audited Internal Controls

Germany Accounting

Boege Rohde Luebbehuesen

An Update On The German LkSG For US-based Multinationals – Draft Amendments And A New Round Of Compliance Inquiries

Germany Commercial

RG

Ropes & Gray LLP

Dynamic German Cannabis Market: Rising Medical Use Today | Recreational Use Tomorrow

In just a few years, Germany has developed into an important sales market for medical cannabis.

Germany Cannabis

GL

Gleiss Lutz

The Digital Act: A Boost For Digitalisation In German Healthcare

Now that both houses of the German parliament have passed the new Digital Act (Digital-Gesetz, "DigiG"), the German healthcare system has certainty regarding the substance of the Act.

Germany Healthcare

GL

Gleiss Lutz

Bundestag Debates Government Bill On Medicines Shortage

In a move to tackle the severe shortage of medicines, the German Federal Government has adopted the draft Act to Improve the Supply of Medicines and Avoid Shortages...

Germany Healthcare

GL

Gleiss Lutz

Cannabis Legalisation In Germany: What Will Change In The Medical Sector?

Not only does the Act partially legalise recreational cannabis, it also signifies important changes in the area of medical cannabis.

Germany Cannabis

GL

Gleiss Lutz

Germany As A Location For Pharmaceutical Businesses - Quo Vadis, 2024?

Germany Healthcare

TW

Taylor Wessing PartG mbB

Trademark Protection In The Life Sciences Business - Why Start-Ups And Founders Should Take Care

Germany Healthcare

TW

Taylor Wessing PartG mbB

OLG Hamburg On The Inadmissibility Of Issuing Pharmaceutical Prescriptions Over The Internet

Germany Healthcare

TW

Taylor Wessing PartG mbB

Important For Start-Ups: Confidentiality Agreements And Material Transfer Agreements (MTAs)

Germany Healthcare

TW

Taylor Wessing PartG mbB

CD Munich, 27 February 2024, Order To Combine Cases In Revocation Actions, UPC_CFI_1/2023, UPC_CFI_14/202

BP

Bardehle Pagenberg

EU MDR And IVDR Implementation: New Transitional Regime Enters Into Force

European Union Healthcare

MF

Morrison & Foerster LLP

Digital Health Laws & Regulations 2023

Germany Healthcare

MW

McDermott Will & Emery

Patent Prosecution

HL

HGF Ltd

EU MDR And IVDR Implementation: European Commission Publishes Full Proposal For Amending Transitional Regime

European Union Healthcare

MF

Morrison & Foerster LLP

Expected Amendments Of The Medical Device Regulation Will Most Likely Increase The Attractiveness Of Investments In The Sector

Germany Healthcare

OP

Oppenhoff

Digital Health Laws & Regulations 2023

German law does not define "digital health" specifically. Generally, the term is interpreted broadly and includes, inter alia: (i) digital healthcare services...

Germany Healthcare

MW

McDermott Will & Emery

Patent Prosecution

Patents are granted for technical inventions. Technically, inventions are usually in the field of engineering, chemistry, pharmaceuticals and physics. In contrast to other jurisdictions...

HL

HGF Ltd

EU MDR And IVDR Implementation: European Commission Publishes Full Proposal For Amending Transitional Regime

Following up on its announcement in the EU Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) Meeting, the European Commission (Commission) released on January 6, 2023...

European Union Healthcare

MF

Morrison & Foerster LLP

Expected Amendments Of The Medical Device Regulation Will Most Likely Increase The Attractiveness Of Investments In The Sector

Investments in the health care sector are very popular since the start of the COVID-19 pandemic. In Germany, there has been a particular interest in the strong German medical technology sector...

Germany Healthcare

OP

Oppenhoff

In Vitro Diagnostic Regulation Entered Into Force (Part 2 Of 3)

European Union Healthcare

MF

Morrison & Foerster LLP

German Federal Government Enacts Tightening Of Investment Review In The Health Sector

On 20 May 2020, the German federal government passed into law the 15th Ordinance amending the Foreign Trade Ordinance (the 15th FTO Amendment).

Germany International

P

POELLATH

Germany Is Going To Specify Safety Expectations For Reimbursable Digital Health Applications

Last month, Germany introduced the Digital Health Service Act, which grants German patients access to reimbursable digital health applications.

Germany Healthcare

HL

Hogan Lovells

No Supplementary Protection Certificate For Medical Devices … At Least For Now

On 25 October 2018, the European Court of Justice ("ECJ") ruled on the Boston Scientific case (Case C-527/17)

European Union Healthcare

MB

Mayer Brown

CJEU Raises Bar For Use Of CRISPR In Europe's Agribusiness: What You Need To Know

Today, the CJEU has issued its much awaited decision on the classification of genome-editing tools such as CRISPR/Cas9, Talen or zinc finger within the framework of the EU's Directive 2001/18/EC...

European Union Healthcare

MF

Morrison & Foerster LLP

Boost For Digital Health In Germany – Restrictions On Remote Treatment Could Be Overturned In May 2018

Germany Healthcare

HL

Hogan Lovells

The Medical Devices Regulation – Key Dates And Roadmap For The Implementation Of The New Rules

European Union Healthcare

MB

Mayer Brown

Germany – A Major Hub For Patent Litigation

Germany Healthcare

RS

Reed Smith (Worldwide)

The Implementation Of The Nagoya Protocol In The EU

European Union IP

TW

Taylor Wessing

The Implementation Of The Nagoya Protocol In Germany

TW

Taylor Wessing

New Rules For Licence And Other Technology Transfer Agreements In The EU

European Union IP

MB

Mayer Brown

A Revolution of Reimbursement in Germany

Germany Healthcare

JD

Jones Day

Methods of Treatment in Europe: Patent Claims Covering Second or Further Medical Uses and Dosage Regimens

JD

Jones Day

G1/07: EPO Enlarged Board Rules on Methods of Surgery

JD

Jones Day

European Court Of Justice (Court Of First Instance): First Decision On Application Proceedings Of A Community Plant Variety Right (Decision Of November 19, 2008 – Case T–187/06 – Schräder v Community Plant Variety Office)

Germany Healthcare

BP

Bardehle Pagenberg

UPDATE: The German Plavix Case: Loopholes In European Data Protection?

Germany Healthcare

JD

Jones Day

The German Plavix Case: Loopholes In European Data Protection?

Germany Healthcare

JD

Jones Day

Overview of the 14th Amendment of the German Drug Act

Germany Healthcare

L

Lovells

Reform of European Pharmaceutical Legislation

Germany Healthcare

MB

Mayer Brown

Reach-Through and Experimental Use: Some Remarks on the Situation in Germany

BP

Bardehle Pagenberg

See more

Latest Videos

See more

What Regulatory Challenges Are Facing The Life Sciences Sector? (Video)

WF

William Fry

Webinar Video | Lunch & Learn: Life Sciences : Morceaux Choisis

A

Altius

Webinar Video | Life Sciences Session #2: Vaccine Liability: What If Vaccination Goes Wrong?

A

Altius

Launch Of Our Medical Device Publication (Video)

WF

William Fry

Understanding Sunshine Rules: How New Transparency Regulations In Europe Are Changing Relationships Between Industry And Health Care Professionals (Video)

HL

Hogan Lovells

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More